Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-09-05

Clinical Trial Update: Mifepristone to Treat Uterine Fibroids [Phase 2, Phase 3]

View source ↗

Summary

A Phase 2/3 clinical trial of mifepristone for uterine fibroids was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Mifepristone (mifepristone)

Snippet

Sponsor: Mediterranea Medica S. L. | Conditions: Uterine Fibroids | Phase 2, Phase 3 | Status: TERMINATED